Friday, 17 Aug 2018

You are here

RheumNow Week in Review - 29 July 2016

Dr Jack Cush reviews this week's highlights from RheumNow.com.

  1. RA: risk of serious infection rises with Interstitial lung dz; 2 fold higher in 1st yr; higher with BOOP & steroids >10mg/day. https://t.co/axzUZhrtHD
  2. FDA warns against using fluoroquinolones (to Rx UTI, bronchitis etc) if other safer Rx options exist. https://t.co/UA0uNmcW3O
  3. Quercetin shown to signif. reduce Uric acid, it inhibits xanthine oxidoreductase in vitro. Not studied in gout. https://t.co/0Fq95UK3PS
  4. CHMP has recommended abatacept for 1st line use (before MTX) in moderate to severe RA. EMA to consider approval https://t.co/kXyD1cXKbO
  5. Anakinra not effective if added to MTX in early RA: CARDERA2 study of 154pts Rx x2yrs. No xray benefit, less DAS/HAQ https://t.co/owvwPhhtss
  6. UK audit of 5000 RA shows only 20% referred from GP to Rheum in 3days (NICE target). Wait time to see Rheum 23-34d https://t.co/5jwIa90EL6
  7. FDA Panel Recommends Brodalumab Approval in Psoriasis
  8. Pravastatin Improves Obstetric Outcomes in Anti-Phospholipid Syndrome Patients. 
  9. Long-Term Safety of Adalimumab Reviewed
  10. MACRA for the Overwhelmed Rheumatologist
  11. The Purse Exam: a Forgotten Part of the Physical. 
Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

ACR Meets With HHS Secretary Azar to Discuss Step Therapy Concerns

Yesterday, the American College of Rheumatology (ACR) met with U.S. Department of Health and Human Services Secretary Alex Azar for a productive discussion about the rheumatology community's concerns with a new policy that will allow Medicare Advantage plans to utilize step therapy in Medicare Part B. In the meeting, the ACR expressed concerns that this policy would delay rheumatology patients' access to treatments.

The RheumNow Week in Review – We’re Number One! (8.17.18)

Dr. Cush reviews the articles and news from the last week on RheumNow.com. Information on comorbidities, the downside of steroids, unmet need in psoriatic arthritis, and the top 10 rheumatology programs.

U.S. News 2018-19 Rheumatology Rankings

The Annual U.S. News and World Report Rankings of Hospitals has listed the top contenders in the field of rheumatology. The U.S. News Review rates hospitals nationwide in 16 specialties – including rheumatology. Of the 4,500 hospitals covered by U.S. News that were analyzed, 158 were classified nationally in at least one specialty area.

The RheumNow Week in Review – No Good Gout (8.10.18)

Dr. Jack Cush reviews the news and latest journal articles from the past week on RheumNow.com. Info on Surgery and Hip Fractures, Gout drugs abandoned, Allopurinol escalation, hydroxychloroquine drug levels, how to treat scleroderma in India and exactly who gets back pain.

The RheumNow Week in Review – Handshakes or Hugs (8.3.18)

Dr. Jack Cush reviews the news and highlights from the past week on RheumNow.com, including new treatments for LTBI, gout consequences, RA and offspring risk, PsA risk, and the opioid epidemic effects.